Effects of the antiarrhythmic agent EGIS-7229 (S 21407) on calcium and potassium currents in canine ventricular cardiomyocytes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-06

AUTHORS

János Magyar, Tamás Bányász, László Fülöp, Norbert Szentandrássy, Ágnes Körtvély, Anikó Kovács, Gábor Szénási, Péter P. Nánási

ABSTRACT

. Based on earlier pharmacological studies performed using conventional microelectrodes EGIS-7229 (S 21407), the novel antiarrhythmic candidate, was suggested to have a combined mode of action in cardiac tissues isolated from various mammalian species. In order to characterize the electrophysiological effects of the compound, its effects on calcium and potassium currents of isolated canine ventricular cardiomyocytes were studied in the present work using the whole cell configuration of the patch clamp technique. L-type Ca current (ICa) was significantly depressed by EGIS-7229 at concentrations of 3 µM or higher with no concomitant changes in the voltage-dependence of activation and time course of inactivation of ICa. The drug reversibly suppressed the rapid component of the delayed rectifier K current (IKr) in a concentration-dependent manner, having a K0.5 value of 1.1±0.1 µM and a slope factor of close to unity (1.23±0.16), indicating that probably one single binding site of high affinity may be involved in binding of EGIS-7229 to the IKr channel. In contrast, no changes in the slow component of the delayed rectifier K current (IKs) was observed with the compound up to the concentration of 100 µM, even if the current was fully activated by 8-bromo-cAMP. At a concentration of 10 µM or higher, EGIS-7229 caused also a moderate but significant reduction in the inward rectifier K current (IK1) and the transient outward K current (Ito) with no change in the voltage-dependence of activation and steady-state inactivation of Ito. Present results indicate that EGIS-7229 can be considered as a selective IKr blocker at low (1 µM) concentration; however, its combined (class III + IV) mechanism of action is evident at concentrations of 3 µM or higher. Suppression of ICa may explain the lack of development of early afterdepolarizations in the presence of EGIS-7229, predicting a relatively safe clinical application in contrast to pure class III compounds. More... »

PAGES

604-611

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002100100409

DOI

http://dx.doi.org/10.1007/s002100100409

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049177907

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11414655


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Arrhythmia Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channels", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electrophysiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patch-Clamp Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium Channels", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridazines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magyar", 
        "givenName": "J\u00e1nos", 
        "id": "sg:person.01206027354.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206027354.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "B\u00e1ny\u00e1sz", 
        "givenName": "Tam\u00e1s", 
        "id": "sg:person.0772313221.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772313221.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "F\u00fcl\u00f6p", 
        "givenName": "L\u00e1szl\u00f3", 
        "id": "sg:person.01331745466.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331745466.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Szentandr\u00e1ssy", 
        "givenName": "Norbert", 
        "id": "sg:person.0741603700.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741603700.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "K\u00f6rtv\u00e9ly", 
        "givenName": "\u00c1gnes", 
        "id": "sg:person.01072716562.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072716562.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.418747.9", 
          "name": [
            "EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kov\u00e1cs", 
        "givenName": "Anik\u00f3", 
        "id": "sg:person.013652432532.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013652432532.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.418747.9", 
          "name": [
            "EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sz\u00e9n\u00e1si", 
        "givenName": "G\u00e1bor", 
        "id": "sg:person.01271103421.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271103421.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "N\u00e1n\u00e1si", 
        "givenName": "P\u00e9ter P.", 
        "id": "sg:person.0724365203.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001-06", 
    "datePublishedReg": "2001-06-01", 
    "description": "Abstract. Based on earlier pharmacological studies performed using conventional microelectrodes EGIS-7229 (S\u00a021407), the novel antiarrhythmic candidate, was suggested to have a combined mode of action in cardiac tissues isolated from various mammalian species. In order to characterize the electrophysiological effects of the compound, its effects on calcium and potassium currents of isolated canine ventricular cardiomyocytes were studied in the present work using the whole cell configuration of the patch clamp technique. L-type Ca current (ICa) was significantly depressed by EGIS-7229 at concentrations of 3\u00a0\u00b5M or higher with no concomitant changes in the voltage-dependence of activation and time course of inactivation of ICa. The drug reversibly suppressed the rapid component of the delayed rectifier K current (IKr) in a concentration-dependent manner, having a K0.5 value of 1.1\u00b10.1\u00a0\u00b5M and a slope factor of close to unity (1.23\u00b10.16), indicating that probably one single binding site of high affinity may be involved in binding of EGIS-7229 to the IKr channel. In contrast, no changes in the slow component of the delayed rectifier K current (IKs) was observed with the compound up to the concentration of 100\u00a0\u00b5M, even if the current was fully activated by 8-bromo-cAMP. At a concentration of 10\u00a0\u00b5M or higher, EGIS-7229 caused also a moderate but significant reduction in the inward rectifier K current (IK1) and the transient outward K current (Ito) with no change in the voltage-dependence of activation and steady-state inactivation of Ito. Present results indicate that EGIS-7229 can be considered as a selective IKr blocker at low (1\u00a0\u00b5M) concentration; however, its combined (class III + IV) mechanism of action is evident at concentrations of 3\u00a0\u00b5M or higher. Suppression of ICa may explain the lack of development of early afterdepolarizations in the presence of EGIS-7229, predicting a relatively safe clinical application in contrast to pure class III compounds.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002100100409", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015404", 
        "issn": [
          "0028-1298", 
          "1432-1912"
        ], 
        "name": "Naunyn-Schmiedeberg's Archives of Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "363"
      }
    ], 
    "keywords": [
      "canine ventricular cardiomyocytes", 
      "rectifier K", 
      "potassium current", 
      "pure class III compounds", 
      "ventricular cardiomyocytes", 
      "selective IKr blocker", 
      "earlier pharmacological studies", 
      "type Ca current", 
      "suppression of ICa", 
      "patch-clamp technique", 
      "transient outward K", 
      "whole-cell configuration", 
      "steady-state inactivation", 
      "mechanism of action", 
      "concentration-dependent manner", 
      "IKr blockers", 
      "safe clinical application", 
      "electrophysiological effects", 
      "IKr channels", 
      "early afterdepolarizations", 
      "clamp technique", 
      "pharmacological studies", 
      "Class III compounds", 
      "Ca current", 
      "inward rectifier K", 
      "rapid component", 
      "mode of action", 
      "cardiac tissue", 
      "clinical applications", 
      "significant reduction", 
      "time course", 
      "cardiomyocytes", 
      "EGIS", 
      "concomitant changes", 
      "slope factor", 
      "activation", 
      "calcium", 
      "high affinity", 
      "mammalian species", 
      "slow component", 
      "ICA", 
      "lack of development", 
      "afterdepolarizations", 
      "blockers", 
      "present results", 
      "K0.5 values", 
      "low concentrations", 
      "drugs", 
      "inactivation", 
      "concentration", 
      "effect", 
      "tissue", 
      "action", 
      "changes", 
      "contrast", 
      "suppression", 
      "course", 
      "cAMP", 
      "factors", 
      "study", 
      "binding", 
      "lack", 
      "reduction", 
      "compounds", 
      "presence", 
      "manner", 
      "mechanism", 
      "candidates", 
      "affinity", 
      "development", 
      "sites", 
      "components", 
      "results", 
      "values", 
      "technique", 
      "current", 
      "channels", 
      "present work", 
      "cell configuration", 
      "species", 
      "order", 
      "mode", 
      "work", 
      "applications", 
      "close", 
      "ITO", 
      "unity", 
      "configuration"
    ], 
    "name": "Effects of the antiarrhythmic agent EGIS-7229 (S 21407) on calcium and potassium currents in canine ventricular cardiomyocytes", 
    "pagination": "604-611", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049177907"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002100100409"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11414655"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002100100409", 
      "https://app.dimensions.ai/details/publication/pub.1049177907"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_346.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002100100409"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002100100409'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002100100409'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002100100409'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002100100409'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      126 URIs      118 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002100100409 schema:about N1997b56ab1274a10bb92b3fbdf2038a5
2 N45dfaf389b2d404d8313cc3fd550b96f
3 N5d74bb1f3199468c88849a47ba0f25cf
4 N725a819aeb444f708a29d758e6a64616
5 N87aabb08b87d48cc8e6e081829ea70fb
6 N981ba14d11fd4c92b377429f6e96f912
7 Nb64d47065e3245b0bb8d61d3fff0a097
8 Nd291b033cecb4bd0904d355ba75bf18b
9 Nd90c0ec7730d4fce815cda2de3ddd52e
10 Ne16cbda18fb04132bb937d3d1d643f6d
11 Nf4d996a8d7fd45f5814a933d00416a3b
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author Na28781c424f1411ca63fec4088af57bf
15 schema:datePublished 2001-06
16 schema:datePublishedReg 2001-06-01
17 schema:description Abstract. Based on earlier pharmacological studies performed using conventional microelectrodes EGIS-7229 (S 21407), the novel antiarrhythmic candidate, was suggested to have a combined mode of action in cardiac tissues isolated from various mammalian species. In order to characterize the electrophysiological effects of the compound, its effects on calcium and potassium currents of isolated canine ventricular cardiomyocytes were studied in the present work using the whole cell configuration of the patch clamp technique. L-type Ca current (ICa) was significantly depressed by EGIS-7229 at concentrations of 3 µM or higher with no concomitant changes in the voltage-dependence of activation and time course of inactivation of ICa. The drug reversibly suppressed the rapid component of the delayed rectifier K current (IKr) in a concentration-dependent manner, having a K0.5 value of 1.1±0.1 µM and a slope factor of close to unity (1.23±0.16), indicating that probably one single binding site of high affinity may be involved in binding of EGIS-7229 to the IKr channel. In contrast, no changes in the slow component of the delayed rectifier K current (IKs) was observed with the compound up to the concentration of 100 µM, even if the current was fully activated by 8-bromo-cAMP. At a concentration of 10 µM or higher, EGIS-7229 caused also a moderate but significant reduction in the inward rectifier K current (IK1) and the transient outward K current (Ito) with no change in the voltage-dependence of activation and steady-state inactivation of Ito. Present results indicate that EGIS-7229 can be considered as a selective IKr blocker at low (1 µM) concentration; however, its combined (class III + IV) mechanism of action is evident at concentrations of 3 µM or higher. Suppression of ICa may explain the lack of development of early afterdepolarizations in the presence of EGIS-7229, predicting a relatively safe clinical application in contrast to pure class III compounds.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N397c2ed4d84346a6a5dfb19961fd089e
22 Nd1bbc94eb8554ed19af2dbf640c06392
23 sg:journal.1015404
24 schema:keywords Ca current
25 Class III compounds
26 EGIS
27 ICA
28 IKr blockers
29 IKr channels
30 ITO
31 K0.5 values
32 action
33 activation
34 affinity
35 afterdepolarizations
36 applications
37 binding
38 blockers
39 cAMP
40 calcium
41 candidates
42 canine ventricular cardiomyocytes
43 cardiac tissue
44 cardiomyocytes
45 cell configuration
46 changes
47 channels
48 clamp technique
49 clinical applications
50 close
51 components
52 compounds
53 concentration
54 concentration-dependent manner
55 concomitant changes
56 configuration
57 contrast
58 course
59 current
60 development
61 drugs
62 earlier pharmacological studies
63 early afterdepolarizations
64 effect
65 electrophysiological effects
66 factors
67 high affinity
68 inactivation
69 inward rectifier K
70 lack
71 lack of development
72 low concentrations
73 mammalian species
74 manner
75 mechanism
76 mechanism of action
77 mode
78 mode of action
79 order
80 patch-clamp technique
81 pharmacological studies
82 potassium current
83 presence
84 present results
85 present work
86 pure class III compounds
87 rapid component
88 rectifier K
89 reduction
90 results
91 safe clinical application
92 selective IKr blocker
93 significant reduction
94 sites
95 slope factor
96 slow component
97 species
98 steady-state inactivation
99 study
100 suppression
101 suppression of ICa
102 technique
103 time course
104 tissue
105 transient outward K
106 type Ca current
107 unity
108 values
109 ventricular cardiomyocytes
110 whole-cell configuration
111 work
112 schema:name Effects of the antiarrhythmic agent EGIS-7229 (S 21407) on calcium and potassium currents in canine ventricular cardiomyocytes
113 schema:pagination 604-611
114 schema:productId N33aca255ba284d2f8d4ae2d8fffd96f8
115 Nb6847041dd724f9692611f5ac0ac3e4d
116 Nd4284b563334471b84c4a7e5cbdb352d
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049177907
118 https://doi.org/10.1007/s002100100409
119 schema:sdDatePublished 2022-05-20T07:21
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher N409134cd0da14ca793087f6aa90bf43e
122 schema:url https://doi.org/10.1007/s002100100409
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N1997b56ab1274a10bb92b3fbdf2038a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Pyridazines
128 rdf:type schema:DefinedTerm
129 N33aca255ba284d2f8d4ae2d8fffd96f8 schema:name dimensions_id
130 schema:value pub.1049177907
131 rdf:type schema:PropertyValue
132 N38c35289a2ad4c9d91ea85c805b236dc rdf:first sg:person.0724365203.35
133 rdf:rest rdf:nil
134 N397c2ed4d84346a6a5dfb19961fd089e schema:volumeNumber 363
135 rdf:type schema:PublicationVolume
136 N409134cd0da14ca793087f6aa90bf43e schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 N45dfaf389b2d404d8313cc3fd550b96f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 N468d3f03c7f8490088c28d8851494913 rdf:first sg:person.01072716562.79
142 rdf:rest Nd5a0dcec89fe45f7be4c47bc17d597fd
143 N5d74bb1f3199468c88849a47ba0f25cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Potassium Channels
145 rdf:type schema:DefinedTerm
146 N725a819aeb444f708a29d758e6a64616 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Dogs
148 rdf:type schema:DefinedTerm
149 N87aabb08b87d48cc8e6e081829ea70fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Analysis of Variance
151 rdf:type schema:DefinedTerm
152 N924c716cc70b42638f8078a36ec2f253 rdf:first sg:person.0772313221.04
153 rdf:rest Ne57a96f215d047ed951d40f51aec38ea
154 N981ba14d11fd4c92b377429f6e96f912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Calcium Channels
156 rdf:type schema:DefinedTerm
157 Na28781c424f1411ca63fec4088af57bf rdf:first sg:person.01206027354.83
158 rdf:rest N924c716cc70b42638f8078a36ec2f253
159 Na5f84549c08d42508092888d7b3bd324 rdf:first sg:person.01271103421.51
160 rdf:rest N38c35289a2ad4c9d91ea85c805b236dc
161 Nb15fefcb97864348a9160a79731709b5 rdf:first sg:person.0741603700.70
162 rdf:rest N468d3f03c7f8490088c28d8851494913
163 Nb64d47065e3245b0bb8d61d3fff0a097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Electrophysiology
165 rdf:type schema:DefinedTerm
166 Nb6847041dd724f9692611f5ac0ac3e4d schema:name doi
167 schema:value 10.1007/s002100100409
168 rdf:type schema:PropertyValue
169 Nd1bbc94eb8554ed19af2dbf640c06392 schema:issueNumber 6
170 rdf:type schema:PublicationIssue
171 Nd291b033cecb4bd0904d355ba75bf18b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Heart
173 rdf:type schema:DefinedTerm
174 Nd4284b563334471b84c4a7e5cbdb352d schema:name pubmed_id
175 schema:value 11414655
176 rdf:type schema:PropertyValue
177 Nd5a0dcec89fe45f7be4c47bc17d597fd rdf:first sg:person.013652432532.38
178 rdf:rest Na5f84549c08d42508092888d7b3bd324
179 Nd90c0ec7730d4fce815cda2de3ddd52e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Patch-Clamp Techniques
181 rdf:type schema:DefinedTerm
182 Ne16cbda18fb04132bb937d3d1d643f6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Animals
184 rdf:type schema:DefinedTerm
185 Ne57a96f215d047ed951d40f51aec38ea rdf:first sg:person.01331745466.46
186 rdf:rest Nb15fefcb97864348a9160a79731709b5
187 Nf4d996a8d7fd45f5814a933d00416a3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Anti-Arrhythmia Agents
189 rdf:type schema:DefinedTerm
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
194 schema:name Pharmacology and Pharmaceutical Sciences
195 rdf:type schema:DefinedTerm
196 sg:journal.1015404 schema:issn 0028-1298
197 1432-1912
198 schema:name Naunyn-Schmiedeberg's Archives of Pharmacology
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01072716562.79 schema:affiliation grid-institutes:grid.7122.6
202 schema:familyName Körtvély
203 schema:givenName Ágnes
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072716562.79
205 rdf:type schema:Person
206 sg:person.01206027354.83 schema:affiliation grid-institutes:grid.7122.6
207 schema:familyName Magyar
208 schema:givenName János
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206027354.83
210 rdf:type schema:Person
211 sg:person.01271103421.51 schema:affiliation grid-institutes:grid.418747.9
212 schema:familyName Szénási
213 schema:givenName Gábor
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271103421.51
215 rdf:type schema:Person
216 sg:person.01331745466.46 schema:affiliation grid-institutes:grid.7122.6
217 schema:familyName Fülöp
218 schema:givenName László
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331745466.46
220 rdf:type schema:Person
221 sg:person.013652432532.38 schema:affiliation grid-institutes:grid.418747.9
222 schema:familyName Kovács
223 schema:givenName Anikó
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013652432532.38
225 rdf:type schema:Person
226 sg:person.0724365203.35 schema:affiliation grid-institutes:grid.7122.6
227 schema:familyName Nánási
228 schema:givenName Péter P.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35
230 rdf:type schema:Person
231 sg:person.0741603700.70 schema:affiliation grid-institutes:grid.7122.6
232 schema:familyName Szentandrássy
233 schema:givenName Norbert
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741603700.70
235 rdf:type schema:Person
236 sg:person.0772313221.04 schema:affiliation grid-institutes:grid.7122.6
237 schema:familyName Bányász
238 schema:givenName Tamás
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772313221.04
240 rdf:type schema:Person
241 grid-institutes:grid.418747.9 schema:alternateName EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary
242 schema:name EGIS Pharmaceuticals Ltd., P.O. Box 100, 1475 Budapest 10, Hungary
243 rdf:type schema:Organization
244 grid-institutes:grid.7122.6 schema:alternateName Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary
245 schema:name Department of Physiology, University Medical School of Debrecen, P.O. Box 22, 4012 Debrecen, Hungary
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...